Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens

Multidrug antimicrobial resistance (AMR) represents a formidable challenge in the therapy of infectious diseases, triggered by the particularly concerning gram-negative <i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>Klebsiella pneumoniae</i>, <i&...

Full description

Saved in:
Bibliographic Details
Main Authors: Giedrė Valdonė Sakalauskienė, Lina Malcienė, Edgaras Stankevičius, Aurelija Radzevičienė
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/1/63
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589305863733248
author Giedrė Valdonė Sakalauskienė
Lina Malcienė
Edgaras Stankevičius
Aurelija Radzevičienė
author_facet Giedrė Valdonė Sakalauskienė
Lina Malcienė
Edgaras Stankevičius
Aurelija Radzevičienė
author_sort Giedrė Valdonė Sakalauskienė
collection DOAJ
description Multidrug antimicrobial resistance (AMR) represents a formidable challenge in the therapy of infectious diseases, triggered by the particularly concerning gram-negative <i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, and <i>Enterobacter</i> spp. (ESKAPE) pathogens. Designated as a “priority” in 2017, these bacteria continue to pose a significant threat in 2024, particularly during the worldwide SARS-CoV-2 pandemic, where coinfections with ESKAPE members contributed to worsened patient outcomes. The declining effectiveness of current treatments against these pathogens has led to an increased disease burden and an increase in mortality rates globally. This review explores the sophisticated mechanisms driving AMR in gram-negative ESKAPE bacteria, focusing on <i>Acinetobacter baumannii</i>, <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, and <i>Enterobacter</i> spp. Key bacterial mechanisms contributing to resistance include limitations in drug uptake, production of antibiotic-degrading enzymes, alterations in drug target sites, and enhanced drug efflux systems. Comprehending these pathways is vital for formulating innovative therapeutic strategies and tackling the ongoing threat posed by these resistant pathogens.
format Article
id doaj-art-0eb43c7553d345019e290148c66232e1
institution Kabale University
issn 2079-6382
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-0eb43c7553d345019e290148c66232e12025-01-24T13:18:48ZengMDPI AGAntibiotics2079-63822025-01-011416310.3390/antibiotics14010063Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE PathogensGiedrė Valdonė Sakalauskienė0Lina Malcienė1Edgaras Stankevičius2Aurelija Radzevičienė3Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaInstitute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaInstitute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaInstitute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaMultidrug antimicrobial resistance (AMR) represents a formidable challenge in the therapy of infectious diseases, triggered by the particularly concerning gram-negative <i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, and <i>Enterobacter</i> spp. (ESKAPE) pathogens. Designated as a “priority” in 2017, these bacteria continue to pose a significant threat in 2024, particularly during the worldwide SARS-CoV-2 pandemic, where coinfections with ESKAPE members contributed to worsened patient outcomes. The declining effectiveness of current treatments against these pathogens has led to an increased disease burden and an increase in mortality rates globally. This review explores the sophisticated mechanisms driving AMR in gram-negative ESKAPE bacteria, focusing on <i>Acinetobacter baumannii</i>, <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, and <i>Enterobacter</i> spp. Key bacterial mechanisms contributing to resistance include limitations in drug uptake, production of antibiotic-degrading enzymes, alterations in drug target sites, and enhanced drug efflux systems. Comprehending these pathways is vital for formulating innovative therapeutic strategies and tackling the ongoing threat posed by these resistant pathogens.https://www.mdpi.com/2079-6382/14/1/63antimicrobial resistancemultidrug-resistant gram-negative ESKAPE pathogensmechanisms of antimicrobial resistance
spellingShingle Giedrė Valdonė Sakalauskienė
Lina Malcienė
Edgaras Stankevičius
Aurelija Radzevičienė
Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
Antibiotics
antimicrobial resistance
multidrug-resistant gram-negative ESKAPE pathogens
mechanisms of antimicrobial resistance
title Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
title_full Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
title_fullStr Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
title_full_unstemmed Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
title_short Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
title_sort unseen enemy mechanisms of multidrug antimicrobial resistance in gram negative eskape pathogens
topic antimicrobial resistance
multidrug-resistant gram-negative ESKAPE pathogens
mechanisms of antimicrobial resistance
url https://www.mdpi.com/2079-6382/14/1/63
work_keys_str_mv AT giedrevaldonesakalauskiene unseenenemymechanismsofmultidrugantimicrobialresistanceingramnegativeeskapepathogens
AT linamalciene unseenenemymechanismsofmultidrugantimicrobialresistanceingramnegativeeskapepathogens
AT edgarasstankevicius unseenenemymechanismsofmultidrugantimicrobialresistanceingramnegativeeskapepathogens
AT aurelijaradzeviciene unseenenemymechanismsofmultidrugantimicrobialresistanceingramnegativeeskapepathogens